4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-002052
President and CEO sold 3,922 shares at $3.27 ($12,825)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-04 | Sale : show line 1 in the form | −3,922 | $3.27 | $12,825 | 608,605 | D |
| Open-market sales · 3,922 sh · avg $3.27 · $12,825 | ||||||
Loading xslF345X03/doc4.xml…